Leukemia & lymphoma/Leukemia and lymphoma · 2017 · 22 citations · 11 references
MedicineOncologyChemotherapyHematologic OncologyMolecular OncologyDose Adjustment In OncologyHematologic Malignancy TherapyLymphoid NeoplasmsAutologous Transplant ConditioningAutologous Transplant PharmacotherapyLymphoma ChemotherapyLymphoma Treatment ResponsePrimary Refractory LymphomaPrognostic Index DevelopmentRelapsed Diffuse Large B-cell LymphomaTreatment Algorithm Development
High-grade B cell lymphoma with MYC and BCL2 rearrangements (double hit) has a poor prognosis with standard R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). We report here a treatment algorithm of DA-EPOCH-R (dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, rituximab) followed by BEAM (carmustine, etoposide, cytarabine, melphalan) autologous transplant in 36 cases of previously untreated double hit lymphoma (DHL) from 2010 to 2015. A high risk International Prognostic Index (IPI) was present in 42% of cases. At median follow-up of 38 months, the 2-year progression free survival (PFS) and overall survival (OS) were 69% (95% CI 54-84%) and 71% (95% CI 56-86%). Eight cases were refractory to induction with 1-year OS 20%, and no factors were predictive for primary refractory disease. Of 28 responders, 17 proceeded to transplant while 11 were observed, primarily due to age and co-morbidities. By 24-week landmark analysis after diagnosis, the 2-year PFS and OS were both 94% (95% CI 83-100%) vs 79% (95% CI 52-100%) for transplant vs observation (p = .59 for both PFS and OS). There was no significant benefit to consolidative transplant in our series, and primary refractory DHL needs novel approaches.
11
Malik E. Juweid, Sigrid Stroobants, Otto S. Hoekstra et al. · Journal of Clinical Oncology · 2007 · 1.3K citations · Full text
Medicine, Nuclear Medicine, Oncology +16
Nathalie A. Johnson, Graham W. Slack, Kerry J. Savage et al. · Journal of Clinical Oncology · 2012 · 973 citations
Medicine, Cancer Biology, Oncology +13
Low-Intensity Therapy in Adults with Burkitt's Lymphoma
Kieron Dunleavy, Stefania Pittaluga, Margaret Shovlin et al. · New England Journal of Medicine · 2013 · 360 citations · Full text
Medicine, Oncology, Pharmacology +9